EGRXEAGLE PHARMACEUTICALS, INC.

Nasdaq eagleus.com


$ 4.42 $ 0.21 (5.01 %)    

Thursday, 02-May-2024 15:59:59 EDT
QQQ $ 429.07 $ 5.38 (1.28 %)
DIA $ 382.31 $ 3.34 (0.88 %)
SPY $ 505.01 $ 4.68 (0.94 %)
TLT $ 88.87 $ 0.38 (0.43 %)
GLD $ 213.12 $ -0.66 (-0.31 %)
$ 4.4
$ 4.27
$ 4.40 x 200
$ 0.00 x 0
$ 4.27 - $ 4.64
$ 3.95 - $ 30.40
99,757
na
57.88M
$ 0.52
$ 4.84
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2023 06-30-2023 10-Q
2 05-09-2023 03-31-2023 10-Q
3 03-23-2023 12-31-2022 10-K
4 11-09-2022 09-30-2022 10-Q
5 08-09-2022 06-30-2022 10-Q
6 05-09-2022 03-31-2022 10-Q
7 03-07-2022 12-31-2021 10-K
8 11-09-2021 09-30-2021 10-Q
9 08-09-2021 06-30-2021 10-Q
10 05-10-2021 03-31-2021 10-Q
11 03-05-2021 12-31-2020 10-K
12 11-02-2020 09-30-2020 10-Q
13 08-10-2020 06-30-2020 10-Q
14 05-11-2020 03-31-2020 10-Q
15 03-02-2020 12-31-2019 10-K
16 11-12-2019 09-30-2019 10-Q
17 08-08-2019 06-30-2019 10-Q
18 05-07-2019 03-31-2019 10-Q
19 02-28-2019 12-31-2018 10-K
20 11-01-2018 09-30-2018 10-Q
21 08-07-2018 06-30-2018 10-Q
22 05-10-2018 03-31-2018 10-Q
23 02-26-2018 12-31-2017 10-K
24 11-08-2017 09-30-2017 10-Q
25 08-09-2017 06-30-2017 10-Q
26 05-08-2017 03-31-2017 10-Q
27 03-15-2017 12-31-2016 10-K
28 11-09-2016 09-30-2016 10-Q
29 08-09-2016 06-30-2016 10-Q
30 05-10-2016 03-31-2016 10-Q
31 02-29-2016 12-31-2015 10-K
32 11-12-2015 09-30-2015 10-Q
33 08-11-2015 06-30-2015 10-Q
34 05-15-2015 03-31-2015 10-Q
35 12-22-2014 09-30-2014 10-K
36 08-11-2014 06-30-2014 10-Q
37 05-15-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 eagle-pharmaceuticals-announces-a-trial-in-progress-presentation-of-phase-23-study-of-intravenous-amisulpride-as-prevention-of-postoperative-nausea-and-vomiting-in-pediatric-patients-at-the-upcoming-society-for-ambulatory-anesthesia-2024-annual-meeting

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today announced that it will deliver a Tri...

 eagle-pharmaceuticals-provides-update-on-bendamustine-intellectual-property-portfolio

United States Court Of Appeals For The Federal Circuit Affirmed The Previously Announced Decision By The United States District...

 eagle-pharmaceuticals-to-present-abstract-on-post-hoc-analysis-of-amisulpride-at-the-77th-pga-in-new-york-city

-- BARHEMSYS® (amisulpride) Injection is the first and only antiemetic approved by the U.S. Food and Drug Administration ("...

 why-patterson-companies-shares-are-trading-lower-by-around-14-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than...

 why-is-eagle-pharmaceuticals-stock-trading-lower-today

Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Scott Tarriff, founder, president, and Chief Executive Officer, announced his re...

 top-4-health-care-stocks-that-could-blast-off-this-quarter

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 eagle-pharmaceuticals-granted-patent-for-pemfexy

Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today announced that the U.S. Patent and T...

 stocks-that-hit-52-week-lows-on-thursday

  On Thursday, 369 companies hit new 52-week lows.

 stocks-that-hit-52-week-lows-on-thursday

  During Thursday's session, 406 companies made new 52-week lows.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION